XFRA CAPITAL ADJUSTMENT INFORMATION

Realtime	Geld	Brief	Zeit
	0,249	0,297	12.04.

Realtime

Geld

Brief

Zeit

0,249

0,297

12.04.

XFRA CAPITAL ADJUSTMENT INFORMATION - 09.04.2025

Das Instrument N7S CA87043J2039 SWEET POISON SPIRITS INC. EQUITY wird cum Kapitalmassnahme gehandelt am 09.04.2025 und ex Kapitalmassnahme am 10.04.2025
The instrument N7S CA87043J2039 SWEET POISON SPIRITS INC. EQUITY is traded cum capital adjustment on 09.04.2025 and ex capital adjustment on 10.04.2025

Das Instrument DMN SE0005162880 DIAMYD MEDICAL B EQUITY wird cum Kapitalmassnahme gehandelt am 09.04.2025 und ex Kapitalmassnahme am 10.04.2025
The instrument DMN SE0005162880 DIAMYD MEDICAL B EQUITY is traded cum capital adjustment on 09.04.2025 and ex capital adjustment on 10.04.2025

Das Instrument 4SA SE0009189608 ACOUSORT AB O.N. EQUITY wird cum Kapitalmassnahme gehandelt am 09.04.2025 und ex Kapitalmassnahme am 10.04.2025
The instrument 4SA SE0009189608 ACOUSORT AB O.N. EQUITY is traded cum capital adjustment on 09.04.2025 and ex capital adjustment on 10.04.2025

Zeit	Aktuelle Nachrichten
Mi	AcouSort AB: Bulletin from the Extraordinary General Meeting of AcouSort AB (publ)	The following resolutions were passed at the Extraordinary General Meeting (the "EGM") of AcouSort AB (publ) (the "Company") on 9 April 2025 in Lund. Rights issue of sharesThe EGM resolved to approve... ► Artikel lesen
Mi	XFRA CAPITAL ADJUSTMENT INFORMATION - 09.04.2025	Das Instrument N7S CA87043J2039 SWEET POISON SPIRITS INC. EQUITY wird cum Kapitalmassnahme gehandelt am 09.04.2025 und ex Kapitalmassnahme am 10.04.2025 The instrument N7S CA87043J2039 SWEET POISON... ► Artikel lesen
26.03.	AcouSort AB: AcouSort's CEO answers questions about the company's rights issue and gives his view on the future	In connection with AcouSort's announcement of its plan to carry out a rights issue, several shareholders have contacted the company with questions regarding both the issue itself and how the management... ► Artikel lesen
19.03.	AcouSort AB: AcouSort in new collaboration to improve sepsis treatment	AcouSort's business strategy relies on early development collaborations to integrate its separation technology in partnering companies' products and systems. The most recent collaboration of this kind... ► Artikel lesen
03.03.	AcouSort AB: AcouSort and Bio-ReCell enter collaboration	AcouSort AB ("AcouSort") and Bio-ReCell Ltd ("Bio-ReCell") announce that the two companies have signed a Letter of Intent to jointly explore developing a system for automated clean-up and isolation... ► Artikel lesen

Zeit

Aktuelle Nachrichten

AcouSort AB: Bulletin from the Extraordinary General Meeting of AcouSort AB (publ)

The following resolutions were passed at the Extraordinary General Meeting (the "EGM") of AcouSort AB (publ) (the "Company") on 9 April 2025 in Lund. Rights issue of sharesThe EGM resolved to approve...
► Artikel lesen

XFRA CAPITAL ADJUSTMENT INFORMATION - 09.04.2025

26.03.

AcouSort AB: AcouSort's CEO answers questions about the company's rights issue and gives his view on the future

In connection with AcouSort's announcement of its plan to carry out a rights issue, several shareholders have contacted the company with questions regarding both the issue itself and how the management...
► Artikel lesen

19.03.

AcouSort AB: AcouSort in new collaboration to improve sepsis treatment

AcouSort's business strategy relies on early development collaborations to integrate its separation technology in partnering companies' products and systems. The most recent collaboration of this kind...
► Artikel lesen

03.03.

AcouSort AB: AcouSort and Bio-ReCell enter collaboration

AcouSort AB ("AcouSort") and Bio-ReCell Ltd ("Bio-ReCell") announce that the two companies have signed a Letter of Intent to jointly explore developing a system for automated clean-up and isolation...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Mi	Diamyd Medical AB (publ): Quarterly Report 2 24/25	Diamyd Medical today announces in its second quarterly report for fiscal year 2024/2025 continued progress toward a transformative regulatory milestone, with early Phase 3 results from the DIAGNODE-3... ► Artikel lesen
Mi	XFRA CAPITAL ADJUSTMENT INFORMATION - 09.04.2025	Das Instrument N7S CA87043J2039 SWEET POISON SPIRITS INC. EQUITY wird cum Kapitalmassnahme gehandelt am 09.04.2025 und ex Kapitalmassnahme am 10.04.2025 The instrument N7S CA87043J2039 SWEET POISON... ► Artikel lesen
21.03.	DIAMYD MEDICAL AB: Diamyd Medical announces additional subscription commitments for upcoming rights issue
17.03.	DIAMYD MEDICAL AB: Diamyd Medical highlights clinical benefits of C-peptide preservation at ATTD 2025
13.03.	Diamyd Medical AB (publ): Diamyd Medical advances AI-powered screening for Type 1 Diabetes within the ASSET Project	Diamyd Medical, in collaboration with Mainly AI and ASSET partners, highlights meaningful progress in AI-driven screening and risk prediction for Type 1 Diabetes at the Advanced Technologies & Treatments... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Diamyd Medical AB (publ): Quarterly Report 2 24/25

Diamyd Medical today announces in its second quarterly report for fiscal year 2024/2025 continued progress toward a transformative regulatory milestone, with early Phase 3 results from the DIAGNODE-3...
► Artikel lesen

XFRA CAPITAL ADJUSTMENT INFORMATION - 09.04.2025

21.03.

DIAMYD MEDICAL AB: Diamyd Medical announces additional subscription commitments for upcoming rights issue

17.03.

DIAMYD MEDICAL AB: Diamyd Medical highlights clinical benefits of C-peptide preservation at ATTD 2025

13.03.

Diamyd Medical AB (publ): Diamyd Medical advances AI-powered screening for Type 1 Diabetes within the ASSET Project

Diamyd Medical, in collaboration with Mainly AI and ASSET partners, highlights meaningful progress in AI-driven screening and risk prediction for Type 1 Diabetes at the Advanced Technologies & Treatments...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Do	XFRA NEW INSTRUMENTS AVAILABLE ON 10.04.2025	The following instruments on XETRA do have their first trading 10.04.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.04.2025 Aktien 1 US7416231022 Primo Brands Corp. 2... ► Artikel lesen
Mi	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 09.04.2025	The following instruments on Boerse Frankfurt do have their last trading day on 09.04.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 09.04.2025ISIN NameCA87043J2039 SWEET... ► Artikel lesen
Mi	XFRA ISIN CHANGE	Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA87043J2039 Hyper Bit Technologies Ltd. 09.04.2025 CA44916F1071 Hyper Bit Technologies Ltd. 10.04.2025 Tausch 1:1 ► Artikel lesen
Mi	XFRA CAPITAL ADJUSTMENT INFORMATION - 09.04.2025	Das Instrument N7S CA87043J2039 SWEET POISON SPIRITS INC. EQUITY wird cum Kapitalmassnahme gehandelt am 09.04.2025 und ex Kapitalmassnahme am 10.04.2025 The instrument N7S CA87043J2039 SWEET POISON... ► Artikel lesen
Di	XFRA N7S: AUSSETZUNG/SUSPENSION	DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSWEET POISON SPIRITS... ► Artikel lesen

Zeit

Aktuelle Nachrichten

XFRA NEW INSTRUMENTS AVAILABLE ON 10.04.2025

The following instruments on XETRA do have their first trading 10.04.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 10.04.2025 Aktien 1 US7416231022 Primo Brands Corp. 2...
► Artikel lesen

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 09.04.2025

The following instruments on Boerse Frankfurt do have their last trading day on 09.04.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 09.04.2025ISIN NameCA87043J2039 SWEET...
► Artikel lesen

XFRA ISIN CHANGE

Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA87043J2039 Hyper Bit Technologies Ltd. 09.04.2025 CA44916F1071 Hyper Bit Technologies Ltd. 10.04.2025 Tausch 1:1
► Artikel lesen

XFRA CAPITAL ADJUSTMENT INFORMATION - 09.04.2025

XFRA N7S: AUSSETZUNG/SUSPENSION

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSWEET POISON SPIRITS...
► Artikel lesen

Unternehmen / Aktien	Kurs	%
ACOUSORT AB	0,261	-1,14 %
DIAMYD MEDICAL AB	0,684	-2,98 %
HYPER BIT TECHNOLOGIES LTD	0,262	0,00 %

Unternehmen / Aktien

Kurs

ACOUSORT AB

0,261

-1,14 %

DIAMYD MEDICAL AB

0,684

-2,98 %

HYPER BIT TECHNOLOGIES LTD

0,262

0,00 %

	Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Xetra-Orderbuch


	Fonds	Kurs	%


	Devisen	Kurs	%


	Rohstoffe	Kurs	%


	Themen	Kurs	%



Erweiterte Suche